Tapentadol ER (CG5503)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tapentadol ER (CG5503), covering 2010-07-23 to 2010-07-23. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain [Phase 3]